QQQ   264.16 (-3.05%)
AAPL   107.12 (-4.19%)
MSFT   200.59 (-3.29%)
FB   249.02 (-2.25%)
GOOGL   1,409.39 (-3.45%)
AMZN   2,999.86 (-4.13%)
NVDA   484.95 (-4.07%)
TSLA   380.36 (-10.34%)
BABA   272.95 (-0.85%)
CGC   14.60 (-8.98%)
GE   6.11 (-2.24%)
MU   49.85 (+0.30%)
AMD   74.73 (-3.82%)
T   27.87 (-2.24%)
F   6.64 (-2.06%)
ACB   5.17 (-29.37%)
GILD   63.09 (-0.49%)
NFLX   470.61 (-4.19%)
DIS   123.28 (-3.09%)
BAC   23.26 (-2.84%)
BA   151.18 (-3.58%)
QQQ   264.16 (-3.05%)
AAPL   107.12 (-4.19%)
MSFT   200.59 (-3.29%)
FB   249.02 (-2.25%)
GOOGL   1,409.39 (-3.45%)
AMZN   2,999.86 (-4.13%)
NVDA   484.95 (-4.07%)
TSLA   380.36 (-10.34%)
BABA   272.95 (-0.85%)
CGC   14.60 (-8.98%)
GE   6.11 (-2.24%)
MU   49.85 (+0.30%)
AMD   74.73 (-3.82%)
T   27.87 (-2.24%)
F   6.64 (-2.06%)
ACB   5.17 (-29.37%)
GILD   63.09 (-0.49%)
NFLX   470.61 (-4.19%)
DIS   123.28 (-3.09%)
BAC   23.26 (-2.84%)
BA   151.18 (-3.58%)
QQQ   264.16 (-3.05%)
AAPL   107.12 (-4.19%)
MSFT   200.59 (-3.29%)
FB   249.02 (-2.25%)
GOOGL   1,409.39 (-3.45%)
AMZN   2,999.86 (-4.13%)
NVDA   484.95 (-4.07%)
TSLA   380.36 (-10.34%)
BABA   272.95 (-0.85%)
CGC   14.60 (-8.98%)
GE   6.11 (-2.24%)
MU   49.85 (+0.30%)
AMD   74.73 (-3.82%)
T   27.87 (-2.24%)
F   6.64 (-2.06%)
ACB   5.17 (-29.37%)
GILD   63.09 (-0.49%)
NFLX   470.61 (-4.19%)
DIS   123.28 (-3.09%)
BAC   23.26 (-2.84%)
BA   151.18 (-3.58%)
QQQ   264.16 (-3.05%)
AAPL   107.12 (-4.19%)
MSFT   200.59 (-3.29%)
FB   249.02 (-2.25%)
GOOGL   1,409.39 (-3.45%)
AMZN   2,999.86 (-4.13%)
NVDA   484.95 (-4.07%)
TSLA   380.36 (-10.34%)
BABA   272.95 (-0.85%)
CGC   14.60 (-8.98%)
GE   6.11 (-2.24%)
MU   49.85 (+0.30%)
AMD   74.73 (-3.82%)
T   27.87 (-2.24%)
F   6.64 (-2.06%)
ACB   5.17 (-29.37%)
GILD   63.09 (-0.49%)
NFLX   470.61 (-4.19%)
DIS   123.28 (-3.09%)
BAC   23.26 (-2.84%)
BA   151.18 (-3.58%)
Log in
NASDAQ:YTEN

Yield10 Bioscience Stock Forecast, Price & News

$7.31
-0.67 (-8.40 %)
(As of 09/23/2020 12:00 AM ET)
Add
Compare
Today's Range
$7.25
Now: $7.31
$7.94
50-Day Range
$4.34
MA: $5.76
$8.00
52-Week Range
$3.50
Now: $7.31
$31.05
Volume114,925 shs
Average Volume796,710 shs
Market Capitalization$20.60 million
P/E RatioN/A
Dividend YieldN/A
Beta2.55
Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing disruptive technologies for enhancing crop yield in the United States and Canada. The company, through its Smart Carbon Grid for Crops and T3 platforms, is involved in improving fundamental crop yield through enhanced photosynthetic carbon capture, as well as increased carbon utilization efficiency to increase seed yield. The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was founded in 1992 and is headquartered in Woburn, Massachusetts.
Read More
Yield10 Bioscience logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.29 out of 5 stars


Industry, Sector and Symbol

Industry Miscellaneous plastics products
Sub-IndustryN/A
Current SymbolNASDAQ:YTEN
CUSIPN/A
Phone617-583-1700

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$810,000.00
Book Value($4.38) per share

Profitability

Net Income$-12,960,000.00
Net Margins-1,861.39%

Miscellaneous

Employees22
Market Cap$20.60 million
Next Earnings Date11/10/2020 (Estimated)
OptionableNot Optionable
$7.31
-0.67 (-8.40 %)
(As of 09/23/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive YTEN News and Ratings via Email

Sign-up to receive the latest news and ratings for YTEN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Yield10 Bioscience (NASDAQ:YTEN) Frequently Asked Questions

How has Yield10 Bioscience's stock been impacted by COVID-19?

Yield10 Bioscience's stock was trading at $4.82 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, YTEN shares have increased by 51.7% and is now trading at $7.31.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Yield10 Bioscience?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Yield10 Bioscience in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Yield10 Bioscience
.

When is Yield10 Bioscience's next earnings date?

Yield10 Bioscience is scheduled to release its next quarterly earnings announcement on Tuesday, November 10th 2020.
View our earnings forecast for Yield10 Bioscience
.

How were Yield10 Bioscience's earnings last quarter?

Yield10 Bioscience Inc (NASDAQ:YTEN) issued its quarterly earnings data on Tuesday, August, 11th. The specialty chemicals company reported ($0.92) earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of ($1.30) by $0.38. Yield10 Bioscience had a negative return on equity of 347.89% and a negative net margin of 1,861.39%.
View Yield10 Bioscience's earnings history
.

When did Yield10 Bioscience's stock split? How did Yield10 Bioscience's stock split work?

Yield10 Bioscience shares reverse split on the morning of Thursday, January 16th 2020. The 1-40 reverse split was announced on Wednesday, January 15th 2020. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, January 15th 2020. An investor that had 100 shares of Yield10 Bioscience stock prior to the reverse split would have 3 shares after the split.

What price target have analysts set for YTEN?

3 brokerages have issued 1 year price targets for Yield10 Bioscience's stock. Their forecasts range from $12.00 to $40.00. On average, they anticipate Yield10 Bioscience's stock price to reach $23.00 in the next year. This suggests a possible upside of 214.6% from the stock's current price.
View analysts' price targets for Yield10 Bioscience
.

Are investors shorting Yield10 Bioscience?

Yield10 Bioscience saw a decline in short interest during the month of August. As of August 31st, there was short interest totaling 44,400 shares, a decline of 22.2% from the August 15th total of 57,100 shares. Based on an average trading volume of 1,240,000 shares, the short-interest ratio is currently 0.0 days. Currently, 2.4% of the company's shares are short sold.
View Yield10 Bioscience's Short Interest
.

Who are some of Yield10 Bioscience's key competitors?

What other stocks do shareholders of Yield10 Bioscience own?

Who are Yield10 Bioscience's key executives?

Yield10 Bioscience's management team includes the following people:
  • Dr. Oliver P. Peoples, Co-Founder, Pres, CEO & Director (Age 61)
  • Dr. Anthony J. Sinskey, Co-Founder & Director (Age 79)
  • Dr. Kristi Snell, VP of Research & Chief Science Officer (Age 51)
  • Ms. Lynne H. Brum, VP of Planning & Communications and Sec. (Age 55)
  • Mr. Charles B. Haaser, VP of Fin., Chief Accounting Officer & Treasurer (Age 63)

What is Yield10 Bioscience's stock symbol?

Yield10 Bioscience trades on the NASDAQ under the ticker symbol "YTEN."

Who are Yield10 Bioscience's major shareholders?

Yield10 Bioscience's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Virtu Financial LLC (0.52%). Company insiders that own Yield10 Bioscience stock include Jack W Schuler and Oliver P Peoples.
View institutional ownership trends for Yield10 Bioscience
.

Which institutional investors are buying Yield10 Bioscience stock?

YTEN stock was acquired by a variety of institutional investors in the last quarter, including Virtu Financial LLC. Company insiders that have bought Yield10 Bioscience stock in the last two years include Jack W Schuler, and Oliver P Peoples.
View insider buying and selling activity for Yield10 Bioscience
.

How do I buy shares of Yield10 Bioscience?

Shares of YTEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Yield10 Bioscience's stock price today?

One share of YTEN stock can currently be purchased for approximately $7.31.

How big of a company is Yield10 Bioscience?

Yield10 Bioscience has a market capitalization of $20.60 million and generates $810,000.00 in revenue each year. The specialty chemicals company earns $-12,960,000.00 in net income (profit) each year or ($35.50) on an earnings per share basis. Yield10 Bioscience employs 22 workers across the globe.

What is Yield10 Bioscience's official website?

The official website for Yield10 Bioscience is www.yield10bio.com.

How can I contact Yield10 Bioscience?

Yield10 Bioscience's mailing address is 19 PRESIDENTIAL WAY, WOBURN MA, 01801. The specialty chemicals company can be reached via phone at 617-583-1700 or via email at [email protected]

This page was last updated on 9/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.